LILRB2

LILRB2

LILRB2 詳細

Molecule Name
Leukocyte immunoglobulin-like receptor subfamily B member 2
分子の別称
LILRB2,ILT4,LIR2,MIR10,CD85d
Drug Development Progress
治験薬の数11
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
Leukocyte immunoglobulin-like receptor 2,CD85 antigen-like family member D,Immunoglobulin-like transcript 4,ILT-4,Monocyte/macrophage immunoglobulin-like receptor 10,MIR-10,CD_antigen: CD85d,LILRB2,Leukocyte Immunoglobulin Like Receptor B2,Leucocyte Ig-Like Receptor B2,MIR10,Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM And ITIM Domains), Member 2,Ig-Like Transcript 4,Myeloid Inhibitory Receptor 10,CD85d Antigen,ILT4,LIR2,CD85d,LIR-2,LIRB2
バックグランド
Leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) is also known as CD85 antigen-like family member D (CD85d), Immunoglobulin-like transcript 4 (ILT-4), Monocyte / macrophage immunoglobulin-like receptor 10 (MIR-10), which is a member of the the subfamily B class of LIR receptors. LILRB2 is receptor for class I MHC antigens. LILRB2 recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. LILRB2 competes with CD8A for binding to class I MHC antigens. LILRB2 / CD85d inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

LILRB2 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

抗体購入プラットフォーム

プロジェクトステージタイプ由来疾患領域適応症
LILRB2 mAb - 01PCCMonoclonalHumanized MouseSolid TumorSolid tumor
プロジェクト
LILRB2 mAb - 01
ステージ
PCC
タイプ
Monoclonal
由来
Humanized Mouse
疾患領域
Solid Tumor
適応症
Solid tumor